Literature DB >> 19065582

Betulinic acid: a natural product with anticancer activity.

Simone Fulda1.   

Abstract

Betulinic acid (BA) is a naturally occurring pentacyclic triterpene that exhibits a variety of biological activities including potent antitumor properties. This anticancer activity has been linked to its ability to directly trigger mitochondrial membrane permeabilization, a central event in the apoptotic process that seals the cell's fate. In contrast to the potent cytotoxicity of BA against a variety of cancer types, nonmalignant cells and normal tissue remained relatively resistant to BA, indicating a therapeutic window. Since agents that exert a direct action on mitochondria may trigger cell death under circumstances in which standard chemotherapeutics fail, there is increasing interest to develop such compounds as experimental cancer therapeutics. Thus, mitochondrion-targeted agents such as BA hold great promise as a novel approach to bypass certain forms of drug resistance in human cancers.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19065582     DOI: 10.1002/mnfr.200700491

Source DB:  PubMed          Journal:  Mol Nutr Food Res        ISSN: 1613-4125            Impact factor:   5.914


  32 in total

1.  Exploration of the antiplatelet activity profile of betulinic acid on human platelets.

Authors:  Andreas G Tzakos; Vassiliki G Kontogianni; Maria Tsoumani; Eleni Kyriakou; John Hwa; Francisco A Rodrigues; Alexandros D Tselepis
Journal:  J Agric Food Chem       Date:  2012-07-03       Impact factor: 5.279

Review 2.  New targets for the antitumor activity of gambogic acid in hematologic malignancies.

Authors:  Li-jing Yang; Yan Chen
Journal:  Acta Pharmacol Sin       Date:  2012-12-31       Impact factor: 6.150

3.  Terpenoids as potential chemopreventive and therapeutic agents in liver cancer.

Authors:  Roslin J Thoppil; Anupam Bishayee
Journal:  World J Hepatol       Date:  2011-09-27

4.  Relationships of diverse apoptotic death process patterns to mitochondrial membrane potential (Δψ(m)) evaluated by three-parameter flow cytometric analysis.

Authors:  Yuhgi Suzuki; Hiroo Hasegawa; Tomohiro Tsuji; Kazuto Tsuruda; Daisuke Sasaki; Kaori Ishihara; Kazuhiro Nagai; Katsunori Yanagihara; Yasuaki Yamada; Shimeru Kamihira
Journal:  Cytotechnology       Date:  2012-06-06       Impact factor: 2.058

5.  3β-Acet-oxy-lup-20(29)-en-28-yl 1H-1,2,4-tri-azole-1-carboxyl-ate.

Authors:  R C Santos; A Matos Beja; J A R Salvador; J A Paixão
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-10-31

6.  Suppression of STAT3 and HIF-1 alpha mediates anti-angiogenic activity of betulinic acid in hypoxic PC-3 prostate cancer cells.

Authors:  Jimin Shin; Hyo-Jeong Lee; Deok-Beom Jung; Ji Hoon Jung; Hyo-Jung Lee; Eun-Ok Lee; Seok Geun Lee; Beom Sang Shim; Seung Hoon Choi; Seong Gyu Ko; Kwang Seok Ahn; Soo-Jin Jeong; Sung-Hoon Kim
Journal:  PLoS One       Date:  2011-06-24       Impact factor: 3.240

7.  NOXA as critical mediator for drug combinations in polychemotherapy.

Authors:  H Ehrhardt; I Höfig; F Wachter; P Obexer; S Fulda; N Terziyska; I Jeremias
Journal:  Cell Death Dis       Date:  2012-06-21       Impact factor: 8.469

8.  Effect of Betulinic acid Extraction from Guava (Psidium guajava Linn.) Leaves Against Human Cholangiocarcinoma Cells.

Authors:  Rassameepen Phonarknguen; Saksit Nobsathian; Kanjana Assawasuparerk
Journal:  Asian Pac J Cancer Prev       Date:  2022-02-01

9.  Betulinic Acid Ameliorates the Severity of Acute Pancreatitis via Inhibition of the NF-κB Signaling Pathway in Mice.

Authors:  Ziqi Zhou; Ji-Won Choi; Joon Yeon Shin; Dong-Uk Kim; Bitna Kweon; Hyuncheol Oh; Youn-Chul Kim; Ho-Joon Song; Gi-Sang Bae; Sung-Joo Park
Journal:  Int J Mol Sci       Date:  2021-06-26       Impact factor: 5.923

10.  Design, synthesis and biological evaluation of novel betulinic acid derivatives.

Authors:  Shengjie Yang; Na Liang; Hu Li; Wei Xue; Deyu Hu; Linhong Jin; Qi Zhao; Song Yang
Journal:  Chem Cent J       Date:  2012-11-23       Impact factor: 4.215

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.